Treatment or prevention of diseases and disorders associated with cells that express IL-6… Grant US-11827700-B2 United States of America 28 Nov 2023
PYRIDOSTIGMINE FOR USE IN THE TREATMENT OF COVID-19 Application WO-2022219372-A1 World Intellectual Property Organisation (WIPO) 20 Oct 2022
USE OF DIAZEPAM AS ONLY TOLERATED BENZODIAZEPINE RECEPTOR AGONIST IN COVID-19 PATIENTS Application WO-2022167685-A1 World Intellectual Property Organisation (WIPO) 11 Aug 2022
USE OF DIAZEPAM AS ONLY TOLERATED BENZODIAZEPINE RECEPTOR AGONIST IN COVID-19 PATIENTS Application EP-4039258-A1 European Patent Office 10 Aug 2022
Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated Salmonella… Grant US-11406702-B1 United States of America 09 Aug 2022
METHOD AND APPARATUS FOR STRATIFYING RESPIRATORY INFECTED PATIENTS Application WO-2022144404-A1 World Intellectual Property Organisation (WIPO) 07 Jul 2022
Method and apparatus for stratifying respiratory infected patients N/A LU-102350-B1 Luxembourg 29 Jun 2022
METHOD FOR PREDICTION OF RISK OF FATAL OUTCOME IN PATIENTS WITH SEVERE AND MODERATE… Application RU-2770357-C1 Russian Federation 15 Apr 2022
TREATMENT OF COVID-19 PATIENTS Application WO-2021239809-A1 World Intellectual Property Organisation (WIPO) 02 Dec 2021
ADENOSINE FOR THE PREVENTION AND TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Application WO-2021240568-A1 World Intellectual Property Organisation (WIPO) 02 Dec 2021
COMPOSITIONS AND METHODS FOR TREATING COVID-19 Application WO-2021205013-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021
NATURAL EXTRACT AND THEIR COMPONENTS FOR USE IN MITIGATING ACUTE RESPIRATORY DISTRESS… Application WO-2021207325-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021
USE OF ANTI-IL-6 ANTIBODY, E.G., CLAZAKIZUMAB FOR TREATMENT/PREVENTION OF ARDS ASSOCIATED… Application WO-2021188727-A1 World Intellectual Property Organisation (WIPO) 23 Sep 2021